Form 8-K - Current report:
SEC Accession No. 0001193125-25-002871
Filing Date
2025-01-07
Accepted
2025-01-07 16:36:04
Documents
15
Period of Report
2025-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d915642d8k.htm   iXBRL 8-K 33582
2 EX-99.1 d915642dex991.htm EX-99.1 1118489
  Complete submission text file 0001193125-25-002871.txt   1539216

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pki-20250107.xsd EX-101.SCH 3882
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pki-20250107_def.xml EX-101.DEF 13242
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pki-20250107_lab.xml EX-101.LAB 21856
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pki-20250107_pre.xml EX-101.PRE 14144
17 EXTRACTED XBRL INSTANCE DOCUMENT d915642d8k_htm.xml XML 5477
Mailing Address 77 4TH AVENUE WALTHAM MA 02451
Business Address 77 4TH AVENUE WALTHAM MA 02451 781-663-6900
REVVITY, INC. (Filer) CIK: 0000031791 (see all company filings)

EIN.: 042052042 | State of Incorp.: MA | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-05075 | Film No.: 25515313
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)